Virus-Related Carcinoma — Trials

Virus-Related Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

169 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 74
Recruiting: 38
Ph III recruiting: 2
Growth YoY: —
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (15)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06508138	Clinical Trial Assessing the Safety and Immunologic Correlates of Heterologous Prime-Boost With pNGVL4a-Sig/E7(Detox)/HSP70 and TA-HPV in Healthy Donors Followed by Peripheral Blood Collection(J21112LINKED)	enrolling by invitation	Phase 1	24	Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER	1	Mar 6, 2026	clinicaltrials

Data updated 22 days agoSource updated Mar 6, 2026source: clinicaltrials